• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与 mA 修饰和细胞坏死相关的参与胰腺导管腺癌免疫浸润的预后标志物。

Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with mA Modification and Necroptosis.

机构信息

College of Life Science, Yangtze University, Jingzhou 434025, China.

Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.

出版信息

Genes (Basel). 2023 Mar 16;14(3):734. doi: 10.3390/genes14030734.

DOI:10.3390/genes14030734
PMID:36981005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10048534/
Abstract

As an important member of the kindlin family, fermitin family member 1 (FERMT1) can interact with integrin and its aberrant expression involves multiple tumors. However, there are few systematic studies on in pancreatic carcinoma (PAAD). We used several public databases to analyze the expression level and clinicopathological characteristics of in PAAD. Meanwhile, the correlation between expression and diagnostic and prognostic value, methylation, potential biological function, immune infiltration, and sensitivity to chemotherapy drugs in PAAD patients were investigated. was significantly up-regulated in PAAD and correlated with T stage, and histologic grade. High expression was closely connected with poor prognosis and can be used to diagnose PAAD. Moreover, the methylation of six CpG sites of was linked to prognosis, and expression was significantly related to N6-methyladenosine (mA) modification. Functional enrichment analysis revealed that co-expression genes participated in diverse biological functions including necroptosis. In addition, the expression of was associated with immune cell infiltration and the expression of immune checkpoint molecules. Finally, overexpression may be sensitive to chemotherapy drugs such as Palbociclib, AM-5992 and TAE-226. can serve as a diagnostic and prognostic marker of PAAD, which is connected with immune cell infiltration and the modulation of mA and necroptosis.

摘要

作为黏着斑激酶家族的重要成员,FERMT1 可以与整合素相互作用,其异常表达涉及多种肿瘤。然而,关于 FERMT1 在胰腺导管腺癌(PAAD)中的研究较少。我们使用了几个公共数据库来分析 FERMT1 在 PAAD 中的表达水平和临床病理特征。同时,研究了 FERMT1 表达与诊断和预后价值、甲基化、潜在生物学功能、免疫浸润以及 PAAD 患者对化疗药物敏感性的相关性。结果表明,FERMT1 在 PAAD 中显著上调,并与 T 分期和组织学分级相关。高表达与预后不良密切相关,可用于诊断 PAAD。此外,FERMT1 的六个 CpG 位点的甲基化与预后相关,并且 FERMT1 表达与 N6-甲基腺苷(mA)修饰显著相关。功能富集分析表明,FERMT1 共表达基因参与了多种生物学功能,包括坏死性凋亡。此外,FERMT1 的表达与免疫细胞浸润和免疫检查点分子的表达相关。最后,过表达 FERMT1 可能对化疗药物如 Palbociclib、AM-5992 和 TAE-226 敏感。FERMT1 可以作为 PAAD 的诊断和预后标志物,与免疫细胞浸润以及 mA 和坏死性凋亡的调节有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/d3a136e3e5b5/genes-14-00734-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/eb6e441192c3/genes-14-00734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/055467026ffd/genes-14-00734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/ead1f2031da5/genes-14-00734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/070fc463b703/genes-14-00734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/07fbfccaa60b/genes-14-00734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/4ad6d7a530e0/genes-14-00734-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/ba70cf514055/genes-14-00734-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/97f0630c1333/genes-14-00734-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/98800a295bae/genes-14-00734-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/d3a136e3e5b5/genes-14-00734-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/eb6e441192c3/genes-14-00734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/055467026ffd/genes-14-00734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/ead1f2031da5/genes-14-00734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/070fc463b703/genes-14-00734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/07fbfccaa60b/genes-14-00734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/4ad6d7a530e0/genes-14-00734-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/ba70cf514055/genes-14-00734-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/97f0630c1333/genes-14-00734-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/98800a295bae/genes-14-00734-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1c3/10048534/d3a136e3e5b5/genes-14-00734-g010.jpg

相似文献

1
Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with mA Modification and Necroptosis.一种与 mA 修饰和细胞坏死相关的参与胰腺导管腺癌免疫浸润的预后标志物。
Genes (Basel). 2023 Mar 16;14(3):734. doi: 10.3390/genes14030734.
2
Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma.新型与坏死性凋亡相关的基因标志物用于预测胰腺腺癌的预后。
Aging (Albany NY). 2022 Jan 24;14(2):869-891. doi: 10.18632/aging.203846.
3
Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma.SP100 家族在胰腺腺癌中的表达、预后价值及其机制。
Aging (Albany NY). 2023 Jun 22;15(12):5569-5591. doi: 10.18632/aging.204811.
4
, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis., 一种胰腺腺癌预后的关键预测因子,显著调控细胞周期、凋亡和转移。
Front Immunol. 2022 Jan 27;13:805311. doi: 10.3389/fimmu.2022.805311. eCollection 2022.
5
Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.胰腺腺癌中N6-甲基腺嘌呤修饰模式与肿瘤免疫微环境分析
Front Genet. 2022 Jan 3;12:752025. doi: 10.3389/fgene.2021.752025. eCollection 2021.
6
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.开发并验证一种新型的 N6-甲基腺苷(m6A)相关多长非编码 RNA(lncRNA)在胰腺腺癌中的预后标志物。
Bioengineered. 2021 Dec;12(1):2432-2448. doi: 10.1080/21655979.2021.1933868.
7
Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.全面分析 m6A RNA 甲基化调控因子与免疫微环境以辅助胰腺癌免疫治疗
Front Immunol. 2021 Nov 5;12:769425. doi: 10.3389/fimmu.2021.769425. eCollection 2021.
8
EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.EIF2Ss,一个新的 c-Myc 相关基因家族,与胰腺导管腺癌的不良预后和免疫浸润相关。
Front Biosci (Landmark Ed). 2024 Mar 21;29(3):119. doi: 10.31083/j.fbl2903119.
9
A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.一种用于胰腺腺癌预后评估的新型免疫检查点评分系统。
BMC Gastroenterol. 2023 Apr 6;23(1):113. doi: 10.1186/s12876-023-02748-w.
10
Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.CENPL mRNA 的过表达可能受 miR-340-3p 调控,可预测胰腺癌患者的预后。
BMC Cancer. 2022 Dec 26;22(1):1354. doi: 10.1186/s12885-022-10450-5.

引用本文的文献

1
Kindlin-1 promotes gastric cancer cell motility through the Wnt/β-catenin signaling pathway.Kindlin-1通过Wnt/β-连环蛋白信号通路促进胃癌细胞的运动。
Sci Rep. 2025 Jan 20;15(1):2481. doi: 10.1038/s41598-025-86220-7.
2
The integrin adhesome and control of anti-tumour immunity.整合素黏附体与抗肿瘤免疫的调控
Biochem Soc Trans. 2024 Dec 19;52(6):2455-2468. doi: 10.1042/BST20240386.
3
Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?基因组、代谢还是免疫:通过非凋亡性细胞死亡决定胰腺癌命运的首要因素是什么?

本文引用的文献

1
The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.2023 年的 STRING 数据库:针对任何感兴趣的测序基因组的蛋白质-蛋白质关联网络和功能富集分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D638-D646. doi: 10.1093/nar/gkac1000.
2
METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.METTL3-IGF2BP3轴通过调节精胺合酶的m6A修饰介导胰腺癌的增殖和迁移。
Front Oncol. 2022 Oct 6;12:962204. doi: 10.3389/fonc.2022.962204. eCollection 2022.
3
Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies.
Biomedicines. 2023 Oct 14;11(10):2792. doi: 10.3390/biomedicines11102792.
胰腺癌:局部区域治疗的挑战与机遇
Cancers (Basel). 2022 Aug 31;14(17):4257. doi: 10.3390/cancers14174257.
4
IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.IGF2BP2 通过促进 B3GNT6 mRNA 的 m6A 甲基化来增强其稳定性,从而促进胰腺癌的进展。
Cancer Med. 2023 Feb;12(4):4405-4420. doi: 10.1002/cam4.5096. Epub 2022 Jul 31.
5
Understanding Necroptosis in Pancreatic Diseases.了解胰腺疾病中的坏死性凋亡
Biomolecules. 2022 Jun 13;12(6):828. doi: 10.3390/biom12060828.
6
Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses.胰腺癌坏死性凋亡的综合分析及其对预后、免疫治疗和化疗反应的影响
Front Pharmacol. 2022 May 18;13:862502. doi: 10.3389/fphar.2022.862502. eCollection 2022.
7
, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis., 一种胰腺腺癌预后的关键预测因子,显著调控细胞周期、凋亡和转移。
Front Immunol. 2022 Jan 27;13:805311. doi: 10.3389/fimmu.2022.805311. eCollection 2022.
8
FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial-mesenchymal transition and cell cycle arrest.FERMT1通过上皮-间质转化和细胞周期阻滞促进鼻咽癌的迁移和侵袭。
Cancer Cell Int. 2022 Feb 10;22(1):70. doi: 10.1186/s12935-022-02494-1.
9
FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.FERMT1 敲低通过使 PI3K/AKT 信号通路失活来抑制口腔鳞状细胞癌细胞上皮-间充质转化。
BMC Oral Health. 2021 Nov 23;21(1):598. doi: 10.1186/s12903-021-01955-9.
10
Wnt signaling pathway in cancer immunotherapy.Wnt 信号通路在癌症免疫治疗中的作用。
Cancer Lett. 2022 Jan 28;525:84-96. doi: 10.1016/j.canlet.2021.10.034. Epub 2021 Nov 3.